Atom Investors LP Supernus Pharmaceuticals, Inc. Transaction History
Atom Investors LP
- $906 Million
- Q3 2024
A detailed history of Atom Investors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Atom Investors LP holds 9,277 shares of SUPN stock, worth $350,113. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,277
Previous 9,106
1.88%
Holding current value
$350,113
Previous $243,000
18.93%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SUPN
# of Institutions
283Shares Held
60.8MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$392 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$231 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$192 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$109 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$99.3 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.02B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...